PAF can inhibit apoptosis in melanoma cells by modulating the expression of anti-apoptotic proteins such as Bcl-2 and Bcl-xL, and by suppressing the activation of pro-apoptotic proteins such as caspases, contributing to the survival of melanoma cells and promoting tumor growth [88]. Here, BCL2L1 is linked to melanoma.